Press Releases

---------------------------------------------------------------- FOR IMMEDIATE RELEASE

CONTACTS:	César García, Chairman and Chief Executive Officer
	818-709-1244
	-or-
	Ron Stabiner, The Wall Street Group, Inc.
	212-888-4848

IRIS TO PRESENT AT MORGAN STANLEY GLOBAL HEALTHCARE UNPLUGGED CONFERENCE MAY 1, 2008

CHATSWORTH, Calif., Apr 09, 2008 - IRIS International, Inc. (NASDAQ GM: IRIS) a leading developer and manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that Chairman, President and Chief Executive Officer César García will present an overview of the Company at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May 1, 2008 at the Ritz Carlton in Key Biscayne, Fla.

Mr. García's presentation is scheduled to begin at 4:20 p.m. Eastern time, and an audio webcast of the presentation will be available live and by replay. To access the live Webcast please visit this link: View Webcast.
A replay will be archived on the Company's web site approximately two hours after the presentation.

THE COMPANY
IRIS International, Inc. (www.proiris.com), based in Chatsworth, Calif., is a leading developer, manufacturer, and marketer of medical devices, diagnostic systems and consumables. The Iris Diagnostics Division (www.irisdiagnostics.com) is a leader in automated urinalysis technology with systems in major medical institutions throughout the world. Iris Molecular Diagnostics develops innovative ultra-sensitive diagnostics and sample processing products with applications in the urinalysis, oncology and infectious disease markets. The Company's Sample Processing business unit (formerly the StatSpin^® subsidiary) (www.statspin.com), based in Westwood, Mass., manufactures innovative centrifuges and blood analysis products.